Written by The global motion sickness treatment market is positioned for steady expansion as growing travel activity, increasing awareness of motion sickness management, and wider access to prescription and over-the-counter treatments continue to influence demand. According to the business intelligence survey by Transparency Market Research, the global motion sickness treatment market was valued at approximately US$670 million in 2017 and is projected to reach nearly US$900 million by 2026, advancing at a significant growth rate of around 3% during the 2018–2026 forecast period. Rising adoption of prescription medicines in developed economies remains a key factor supporting market development, while the increasing number of travelers across developing economies is creating additional opportunities for treatment manufacturers and suppliers. Greater consumer awareness regarding preventive treatment, combined with the availability of convenient oral and transdermal solutions, is also expected to strengthen market demand.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39320
Market Size and Growth
Market growth is being supported by the expanding global travel ecosystem, including air, road, rail, and marine transportation. Motion sickness remains a common concern among travelers, encouraging consumers to seek preventive and symptomatic treatment options. Developed markets are benefiting from the continued use of prescription medications, while emerging markets offer substantial potential as disposable incomes, healthcare access, and travel frequency increase. The growing preference for easily accessible over-the-counter products is another important contributor to market expansion. In addition, pharmaceutical companies are investing in product development, distribution networks, and regional market penetration, helping broaden access to motion sickness treatments.
Market Segmentation
The motion sickness treatment market can be segmented according to treatment type, route of administration, and distribution channel. Treatment categories include antihistamines, sympathomimetic drugs, wearable relief bands, anticholinergic drugs, and traditional medicines, among others. Anticholinergic drugs are expected to maintain a leading position in terms of demand, followed by antihistamines. Based on the route of administration, the market is divided into transdermal and oral treatments, with transdermal products anticipated to account for a significant share because of their convenience and sustained delivery characteristics. By distribution channel, the market includes online pharmacies, drug stores, hospital pharmacies, and retail pharmacies. Retail pharmacies held the leading position in 2017 and are expected to remain influential as consumers continue to rely on easily accessible treatments.
Regional Analysis
North America dominated the global motion sickness treatment market, supported by strong adoption of prescription treatments and comparatively high healthcare spending, particularly in the United States. The region benefits from established pharmaceutical distribution systems and high consumer awareness. Meanwhile, Asia Pacific is expected to provide significant growth opportunities over the forecast period. Rising travel activity, expanding healthcare infrastructure, and increasing participation by multinational pharmaceutical companies are expected to support regional demand. Europe and other emerging markets are also likely to contribute to market development as awareness of motion sickness treatments and access to pharmaceutical products continue to improve.
Competitive Landscape
The competitive environment includes established pharmaceutical companies as well as specialized manufacturers of motion sickness solutions. Key players identified in the market include Perrigo Company plc, WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co., Ltd., Reliefband Technologies LLC, GlaxoSmithKline plc, Prestige Brands, Inc., Caleb Pharmaceuticals, Inc., and Baxter International, Inc. Companies are focusing on expanding their consumer base, strengthening regional distribution, broadening product portfolios, and introducing convenient treatment formats. Product differentiation, brand recognition, accessibility, and technological innovation are expected to remain important competitive factors.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453